AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4790 out of 4974 analysts
Average Return
-4.99%
Win Rate
40%53 out of 131
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +137.93% | $5.88 | $13.99 | 2024-01-16 - 2025-01-15 | Buy |
Verve Therapeutics IncVERV | +123.05% | $4.99 | $11.13 | 2024-08-09 - 2025-07-25 | Buy |
Meiragtx Holdings PLCMGTX | +86.73% | $4.22 | $7.88 | 2024-08-13 - 2025-08-08 | Buy |
Uniqure NvQURE | +85.47% | $7.16 | $13.28 | 2024-11-06 - 2025-08-08 | Buy |
Verve Therapeutics IncVERV | +81.86% | $6.12 | $11.13 | 2025-03-04 - 2025-07-25 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regenxbio IncRGNX | 9 | Buy | $17.00 | +116.56% | Maintains | 2 days ago |
Intellia Therapeutics IncNTLA | 5 | Buy | $21.00 | +94.62% | Maintains | 2 days ago |
Ascendis Pharma AASND | 3 | Buy | $230.00 | +20.11% | Maintains | 2 days ago |
Arrowhead Pharmaceuticals IncARWR | 9 | Buy | $38.00 | +131.43% | Maintains | 2 days ago |
Crispr Therapeutics AgCRSP | 13 | Hold | $42.00 | -23.64% | Maintains | 6 days ago |
Fulcrum Therapeutics IncFULC | 1 | Hold | $5.00 | -22.96% | Maintains | 11 days ago |
Dyne Therapeutics IncDYN | 3 | Buy | $23.00 | +106.09% | Maintains | 12 days ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $4.00 | +74.67% | Maintains | 3 months ago |
Allogene Therapeutics IncALLO | 8 | Buy | $10.00 | +861.54% | Reiterates | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 7 | Hold | $18.00 | -26.14% | Maintains | 3 months ago |
Moderna IncMRNA | 17 | Hold | $28.00 | +7.20% | Maintains | 3 months ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | +341.50% | Maintains | 5 months ago |
Alnylam Pharmaceuticals IncALNY | 26 | Buy | $330.00 | -24.82% | Maintains | 5 months ago |
Korro Bio IncKRRO | 7 | Buy | $95.00 | +493.75% | Maintains | 5 months ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | +337.64% | Reiterates | 5 months ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | +39.23% | Initiates Coverage On | 5 months ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | +64.97% | Maintains | 5 months ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | +34.77% | Maintains | 5 months ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | +521.67% | Maintains | 5 months ago |
Beam Therapeutics IncBEAM | 7 | Hold | $26.00 | +47.56% | Maintains | 5 months ago |
Ionis Pharmaceuticals IncIONS | 8 | Buy | $70.00 | +68.11% | Reiterates | 6 months ago |
Biomarin Pharmaceutical IncBMRN | 12 | Hold | $70.00 | +22.10% | Reiterates | 6 months ago |
Uniqure NvQURE | 6 | Buy | $24.00 | +80.72% | Reiterates | 7 months ago |
Schlumberger LimitedSLB | 1 | Buy | $57.00 | +73.41% | Reiterates | 7 months ago |
Avidity Biosciences IncRNA | 2 | Buy | $67.00 | +44.74% | Reiterates | 7 months ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | +81.00% | Maintains | 8 months ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | +1,509.66% | Reiterates | 9 months ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Buy | $77.00 | +179.59% | Reiterates | 9 months ago |
Wave Life Sciences LtdWVE | 5 | Hold | $15.00 | +85.41% | Maintains | 10 months ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | N/A | Reiterates | a year ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.